HPLC-ESI+-MS/MS analysis of N7-guanine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene
- PMID: 17455958
- DOI: 10.1021/tx700020q
HPLC-ESI+-MS/MS analysis of N7-guanine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene
Abstract
1,3-butadiene (BD) is a major industrial chemical used in rubber and plastics production and is recognized as an animal and human carcinogen. Although the exact mechanism of BD-induced carcinogenesis is unknown, chemical reactions of epoxide metabolites of BD with DNA to form nucleobase adducts are likely to contribute to multistage carcinogenesis. Among BD-derived epoxy metabolites, 1,2:3,4-diepoxybutane (DEB) appears to be the most genotoxic and carcinogenic, probably because of its bifunctional nature. Initial DNA alkylation by DEB produces N7-(2'-hydroxy-3',4'-epoxybut-1'-yl)guanine monoadducts, which can then be hydrolyzed to N7-(2',3',4'-trihydroxy-1'-yl)guanine or can react with another site in double-stranded DNA to form 1,4-bis(guan-7-yl)-2,3-butanediol (bis-N7G-BD) cross-links. While (2',3',4'-trihydroxy-1'-yl)guanine lesions have been previously quantified in vivo, they cannot be used as a biomarker of DEB because the same lesions are also formed by another, more prevalent BD metabolite, 1,2-epoxy-3,4-butanediol. In contrast, bis-N7G-BD can only be formed from DEB, potentially providing a specific biomarker of DEB formation. We have developed a quantitative HPLC-ESI+-MS/MS method for measuring racemic and meso forms of bis-N7G-BD in DNA extracted from tissues of BD-exposed laboratory animals. In our approach, bis-N7G-BD adducts are released from DNA as free bases by neutral thermal hydrolysis, purified by solid-phase extraction, and subjected to HPLC-ESI+-MS/MS analysis. Selected reaction monitoring is performed by following the loss of a guanine moiety from protonated molecules of bis-N7G-BD and the formation of protonated guanine under collision-induced dissociation. Quantitative analysis of racemic and meso forms of bis-N7G-BD is based on isotope dilution with the corresponding 15N-labeled internal standards. The lower limit of quantification of our current method is 10-20 fmol/0.1 mg of DNA. The accuracy and precision of the new method were determined by spiking control mouse liver DNA with racemic and meso forms of bis-N7G-BD (10 fmol each), followed by sample processing and HPLC-ESI+-MS/MS analysis. Calculated amounts of racemic and meso forms of bis-N7G-BD were within 20% of the theoretical value (9.7 +/- 2 and 9.2 +/- 1.9 fmol, respectively, N = 4). DNA extracted from liver and lung tissues of mice exposed to 625 ppm butadiene for 5 days contained 3.2 +/- 0.4 and 1.8 +/- 0.5 racemic adducts per 10(6) guanines, respectively, while the amounts of meso-bis-N7G-BD were below the detection limits of our method (1 per 10(7) guanines). Control animals did not contain either bis-N7G-BD lesion. Sensitive and specific quantitative methods for bis-N7G-BD analysis developed in this work provide a unique biomarker of DEB-induced DNA alkylation following exposure to BD.
Similar articles
-
Quantitative high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry analysis of the adenine-guanine cross-links of 1,2,3,4-diepoxybutane in tissues of butadiene-exposed B6C3F1 mice.Chem Res Toxicol. 2008 May;21(5):1163-70. doi: 10.1021/tx800051y. Epub 2008 Apr 29. Chem Res Toxicol. 2008. PMID: 18442269 Free PMC article.
-
Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.Chem Res Toxicol. 1999 Jul;12(7):566-74. doi: 10.1021/tx980265f. Chem Res Toxicol. 1999. PMID: 10409395
-
1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.Res Rep Health Eff Inst. 2000 Mar;(92):151-90; discussion 211-9. Res Rep Health Eff Inst. 2000. PMID: 10925841
-
DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.Cancer Detect Prev. 1997;21(5):391-405. Cancer Detect Prev. 1997. PMID: 9307842 Review.
-
DNA adducts: mass spectrometry methods and future prospects.Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):293-301. doi: 10.1016/j.taap.2004.12.020. Toxicol Appl Pharmacol. 2005. PMID: 15990134 Review.
Cited by
-
Human exposure to selected animal neurocarcinogens: a biomarker-based assessment and implications for brain tumor epidemiology.J Toxicol Environ Health B Crit Rev. 2009 Mar;12(3):175-87. doi: 10.1080/10937400902894152. J Toxicol Environ Health B Crit Rev. 2009. PMID: 19466671 Free PMC article. Review.
-
Cellular Repair of DNA-DNA Cross-Links Induced by 1,2,3,4-Diepoxybutane.Int J Mol Sci. 2017 May 18;18(5):1086. doi: 10.3390/ijms18051086. Int J Mol Sci. 2017. PMID: 28524082 Free PMC article.
-
Quantitation of DNA adducts by stable isotope dilution mass spectrometry.Chem Res Toxicol. 2012 Oct 15;25(10):2007-35. doi: 10.1021/tx3002548. Epub 2012 Aug 28. Chem Res Toxicol. 2012. PMID: 22827593 Free PMC article. Review.
-
Major groove orientation of the (2S)-N(6)-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine DNA adduct induced by 1,2-epoxy-3-butene.Chem Res Toxicol. 2014 Oct 20;27(10):1675-86. doi: 10.1021/tx500159w. Epub 2014 Sep 19. Chem Res Toxicol. 2014. PMID: 25238403 Free PMC article.
-
Mass spectrometry of structurally modified DNA.Chem Rev. 2013 Apr 10;113(4):2395-436. doi: 10.1021/cr300391r. Epub 2013 Feb 26. Chem Rev. 2013. PMID: 23441727 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous